Overview
$732,094
Office budget mix
- 57% Salaries
- 27% Travel
- 1% Hospitality
- 15% Contracts
Official profile (ourcommons.ca)Sources: ethicscanada.ca, openparliament.ca

71.5/100
#269 of 343 MPs
Score based on 8 of 12 factors.
Attendance
97%
1218 divisions
BILLS SPONSORED
1
1 on file
Office spending
$177,417
Latest quarter: FY 2027 Q1
Conflicts of interest
0
None flagged in the last 12 months
Integrity score
High data confidenceClick any factor to see what it measures
Dan Mazier (Conservative) represents Riding Mountain in the House of Commons. The Integrity Index score for this profile is 71.5 out of 100 (grade C), above the site-wide average of 69.3; the breakdown below shows how it is calculated.
Of the 1,218 recorded divisions in the House of Commons over the period covered, Mazier cast a ballot in 1,177 (97%). Those ballots split 591 in favour and 586 against. Mazier's most recent recorded vote, on October 8, 2026, was in favour of Bill C-39, “Building Canada Strong Act”, which passed.
Mazier is listed as the sponsor of 1 bill. That bill is “An Act to amend the Controlled Drugs and Substances Act (supervised drug consumption sites)”. Mazier sits on 2 committees: Subcommittee on Agenda and Procedure and Government Operations and Estimates.
The record holds 9 public disclosure filings for Mazier, from 2020 to 2026. No potential conflicts of interest are currently flagged. Parliamentary pay for fiscal 2026 is $217,700. Reported office spending through June 30, 2026 totals $732,094, mostly staff salaries (57%).
This summary is written automatically from the public records on this page and updates when they sync. It describes what the records show; it is not an assessment of conduct.
Voted Yea in 591 recorded votes · Nay in 586 · Missed 41
Voted with party
Party-line comparison not yet calculated for this member.
Recent votes
$732,094
Office budget mix
ciec_public_declaration
ciec_public_declaration
ciec_public_declaration
ciec_public_declaration
ciec_public_declaration
LEGISLATION
An Act to amend the Controlled Drugs and Substances Act (supervised drug consumption sites)